Reaction equation
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9]1[C:29](=[O:30])[N:28]([CH3:31])[C:12]2[N:13]([CH3:27])[C:14]3[C:19]([C:11]=2[CH:10]=1)=[CH:18][C:17]([C:20](=O)[CH:21]=[CH:22]N(C)C)=[CH:16][CH:15]=3.Cl.[CH:33]1([NH:39][NH2:40])[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1>>[CH:33]1([N:39]2[C:20]([C:17]3[CH:18]=[C:19]4[C:14](=[CH:15][CH:16]=3)[N:13]([CH3:27])[C:12]3[N:28]([CH3:31])[C:29](=[O:30])[C:9]([C:3]5[CH:4]=[CH:5][C:6]([Cl:8])=[CH:7][C:2]=5[Cl:1])=[CH:10][C:11]4=3)=[CH:21][CH:22]=[N:40]2)[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1Participants
3
Procedure
The process is carried out as in Example 37 above, with the compound from preparation 1.10, 3-(2,4-dichlorophenyl)-6-[3-(dimethylamino)prop-2-enoyl]-1,9-dimethyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one and cyclohexylhydrazine hydrochloride.
Sources & evidence
- ORD record
- ord-e95655b3652a471e9c9c2a01293a5670
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08063061B2
Linked notes
Loading…